To further investigate the biological processes of these targets, the KEGG pathway analysis was conducted and yielded 181 items (p<0.01), and the 16 pathways associated with NAFLD were displayed in Figure 5(d) with pathways in cancer, Th17 cell differentiation, and IL-17 signaling pathway as the top ones, indicating they might be essential pathways of FLD for NAFLD treatment and are worthy of further study. The gene discussed is IL17A; the disease is metabolic dysfunction-associated steatotic liver disease.